Axogen
Florida-based Axogen, Inc. manufactures and distributes medical instruments for nerve reconstruction and regeneration.
Founded
2002Florida-based Axogen, Inc. manufactures and distributes medical instruments for nerve reconstruction and regeneration.
Founded on January 1, 2002, Axogen, Inc. is a Florida-based company specializing in the development and distribution of medical instruments for peripheral nerve reconstruction and regeneration. The company's core mission is to restore functionality and sensation to patients suffering from nerve damage. Axogen's product portfolio includes human tissue grafts, nerve connectors, and soft tissue membranes, with its flagship technology being AVANCE, a cell graft that mimics human nerves. The company primarily serves medical professionals and patients experiencing chronic pain or loss of function due to nerve damage.
Axogen is publicly traded on Nasdaq under the ticker AXGN and is a component of the Russell 2000 Index. In 2013, the company successfully raised $18 million through its initial public offering (IPO). Notable achievements include the widespread adoption of its nerve repair solutions in the medical community, significantly impacting patient recovery outcomes. Axogen's innovative approach has positioned it as a leader in the nerve repair industry, contributing to advancements in surgical techniques and improving the quality of life for countless patients.
Companies similar to Axogen include Axonia Medical, Axoft, Axonics and Audax Medical.
Axogen was founded in 2002.
Axogen's headquarters is located in Alachua, FL, US.
Axogen's most recent funding round was for $17.5M (USD) in August 2015.
As of Aug 28, 2015, Axogen has disclosed funding of $90.9M (USD). Undisclosed round amounts are excluded.
Axogen has 396 employees as of Feb 6, 2024.
audaxmed.com
